What is the market doing?
What the tape says about TEVA
Teva Pharmaceutical Industries Limited is +133% over the past year while the S&P 500 is +23%: 110 points ahead of the market.
+133%
1-year return · S&P 500 +23%
- vs 200-day average
- +21%
vs 200-day average · a clear uptrend
- RSI (14)
- 73
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −0.37%
Below its 52-week high
Details›
- Last close2026-08-26
- $37.96
- 1 monthS&P 500 +3.7%
- +22%
- 1 yearS&P 500 +23%
- +133%
- 5 yearsS&P 500 +87%
- +285%
- vs 50-day average$34.06
- +11%
- 52-week high
- $38.10
- 52-week low
- $16.37
- Annualised volatility
- 44%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$9.6M
| Year | Return |
|---|---|
| 2026 (year to date) | +22% |
| 2025 | +42% |
| 2024 | +111% |
| 2023 | +14% |
| 2022 | +14% |
| 2021 | −17% |
| 2020 | −1.5% |
| 2019 | −36% |
| 2018 | −19% |
| 2017 | −46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 8 of 10 | +8.3% |
| Feb | 10 | 3 of 10 | −2.4% |
| Mar | 10 | 3 of 10 | −4.4% |
| Apr | 10 | 4 of 10 | +2.1% |
| May | 10 | 6 of 10 | −0.52% |
| Jun | 10 | 4 of 10 | +1.2% |
| Jul | 11 | 4 of 11 | +0.79% |
| Aug | 11 | 4 of 11 | −2.7% |
| Sep | 10 | 4 of 10 | −1.0% |
| Oct | 10 | 4 of 10 | −3.3% |
| Nov | 10 | 6 of 10 | +7.0% |
| Dec | 10 | 6 of 10 | +4.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #15 of 28 by Smart Score